MPO and colitis: Another study reported that berberine is involved in the protection of the intestinal barrier, not only by reducing pro-inflammatory cytokines and oxidative stress mediators such as myeloperoxidase (MPO), but also by increasing the expression of tight junction proteins such as zonula occludin-1 (ZO-1), resulting in relieving colitic symptoms in DSS-induced colitis mice [154].